Falsified Medical Product Alert N°3/2024
Oxymorphone Hydrochloride 40mg tablets: falsified product alert
WHO issued this alert on one falsified batch detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency. The tablets contained metonitazene, a potent synthetic opioid with no recognised medicinal use, instead of oxymorphone. The bottle label has no barcode and no US National Drug Code.1
- Issued
- 5 August 2024
- Issued by
- World Health Organization
- Name stated on packaging
- The falsified product imitates Oxymorphone Hydrochloride marketed by AUROLIFE PHARMA LLC. It is labelled 40mg, a strength the genuine product does not come in.
- Genuine manufacturer's statement
- WHO said AUROLIFE PHARMA LLC confirmed the product is falsified and was not produced by their company.
- Countries where detected
- Finland
Batches named in the alert
One batch, listed in the annex to the alert
Advice as stated
Do not use these products. Seek immediate medical advice or contact a poison control centre after use. Report suspected falsification to the national regulator.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg (5 August 2024)